Are Edwards Lifesciences (EW) Shares a Sell Now? Guggenheim Has Downgraded Stock

October 2, 2018 - By Clifton Ray

Edwards Lifesciences Corporation (NYSE:EW) Logo

Edwards Lifesciences (EW) Receives a Downgrade

In a note revealed to investors on Tuesday morning, Guggenheim downgraded shares of Edwards Lifesciences (EW) to a lower Neutral rating from the previous Buy rating.

The stock decreased 4.26% or $7.27 during the last trading session, reaching $163.55. About 1.90 million shares traded or 50.54% up from the average. Edwards Lifesciences Corporation (EW) has risen 26.36% since October 2, 2017 and is uptrending. It has outperformed by 10.74% the S&P500.

Analysts await Edwards Lifesciences Corporation (NYSE:EW) to report earnings on October, 23. They expect $1.02 EPS, up 21.43 % or $0.18 from last year’s $0.84 per share. EW’s profit will be $213.57M for 40.09 P/E if the $1.02 EPS becomes a reality. After $1.24 actual EPS reported by Edwards Lifesciences Corporation for the previous quarter, Wall Street now forecasts -17.74 % negative EPS growth.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company has market cap of $34.25 billion. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. It has a 53.71 P/E ratio. The firm also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patientÂ’s diseased or defective heart valve.

More notable recent Edwards Lifesciences Corporation (NYSE:EW) news were published by: Streetinsider.com which released: “BofA/Merrill Lynch Downgrades Edwards Lifesciences (EW) to Neutral” on October 02, 2018, also Streetinsider.com with their article: “Pre-Open Movers 10/02: (DTEA) (OMER) (CLVS) Higher; (SFIX) (NBEV) (VNE) Lower (more…)” published on October 02, 2018, Ocbj.com published: “Midday Stock Roundup” on October 02, 2018. More interesting news about Edwards Lifesciences Corporation (NYSE:EW) were released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” published on October 02, 2018 as well as Benzinga.com‘s news article titled: “24 Stocks Moving In Tuesday’s Pre-Market Session” with publication date: October 02, 2018.

Edwards Lifesciences Corporation (NYSE:EW) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>